Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study (Q64693500)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study
clinical trial

    Statements

    CERTAIN 2 (English)
    0 references
    A Phase IIIB, Multi-center, Open Label Follow-up Study to Evaluate the Safety and Efficacy of Certolizumab Pegol Administered Concomitantly With DMARDs in Patients With Active Rheumatoid Arthritis Who Participated in C87076. (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    January 2009
    0 references
    December 2012
    0 references
    131
    0 references
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit